Edition:
United Kingdom

People: AtriCure Inc (ATRC.OQ)

ATRC.OQ on NASDAQ Stock Exchange Global Market

26.42USD
23 Aug 2019
Change (% chg)

$-0.28 (-1.05%)
Prev Close
$26.70
Open
$26.57
Day's High
$27.15
Day's Low
$26.35
Volume
111,328
Avg. Vol
75,237
52-wk High
$36.08
52-wk Low
$26.15

Seith, Douglas 

Mr. Douglas J. Seith is Chief Operating Officer of AtriCure Inc. He having previously served as our Senior Vice President, Sales and Marketing from 2013 to 2014 and as our Vice President, United States Sales from 2011 to 2013. Since joining AtriCure in 2004 as a Regional Sales Leader, Mr. Seith has held a variety of progressive sales and sales leadership positions, including Area Director roles. Mr. Seith has over 25 years of cardiology and general surgery sales and sales leadership experience. Prior to joining AtriCure, Mr. Seith held sales leadership and/or sales positions with A-Med/EmoblX, Inc., where he was the Vice President of Sales, Heartport, Inc., Scimed Life Systems, a division of Boston Scientific, Inc. and Automated Instruments (a division of Unites States Surgical Corporation). Mr. Seith received his B.A. from Ohio Wesleyan University.

Basic Compensation

Total Annual Compensation, USD 928,559
Restricted Stock Award, USD 849,974
Long-Term Incentive Plans, USD --
All Other, USD 15,450
Fiscal Year Total, USD 1,793,980

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 58,112 1,243,080.00
Name Fiscal Year Total

Scott Drake

216,428

Michael Carrel

3,808,000

Andrew Wade

1,550,780

Douglas Seith

1,793,980

Justin Noznesky

1,218,180

Salvatore Privitera

1,120,830
As Of  31 Dec 2018